IQVIA Holdings Inc
NYSE:IQV
IQVIA Holdings Inc
Other
IQVIA Holdings Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other
-$17m
|
CAGR 3-Years
73%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other
$194m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
13%
|
|
|
Danaher Corp
NYSE:DHR
|
Other
-$131m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-20%
|
|
|
Waters Corp
NYSE:WAT
|
Other
$16.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
16%
|
CAGR 10-Years
1%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other
-$11m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other
-$36m
|
CAGR 3-Years
21%
|
CAGR 5-Years
2%
|
CAGR 10-Years
27%
|
|
IQVIA Holdings Inc
Glance View
In the world of healthcare, IQVIA Holdings Inc. emerges as a formidable player, seamlessly blending data analytics with the imperative of human well-being. Born from the merger of IMS Health and Quintiles in 2016, IQVIA stands at the intersection of technology and life sciences, leveraging vast amounts of health-related data to facilitate more informed decisions in drug development and patient care. The company's vast repository consists of a complex tapestry of dynamic insights from around the globe, which it transforms using sophisticated analytical tools. This technical prowess enables IQVIA to offer solutions that span clinical trials, health information services, and advanced analytics, creating substantial value for pharmaceutical and life sciences companies. At the heart of IQVIA’s revenue model lies its ability to provide strategic services that reduce the time and cost associated with the development of new pharmaceuticals. By offering an integrated suite of services from the initial phases of drug research to post-market monitoring, IQVIA assists its clients in navigating regulatory landscapes and commercializing their products effectively. Its expansive technological infrastructure does not just aid in drug development but also enhances patient engagement, creating digital pathways for more personalized healthcare solutions. Thus, IQVIA earns its keep by not only selling information but also by offering transformative insights that sharpen the competitive edge for its clients in the ever-evolving healthcare sector.
See Also
What is IQVIA Holdings Inc's Other?
Other
-17m
USD
Based on the financial report for Dec 31, 2024, IQVIA Holdings Inc's Other amounts to -17m USD.
What is IQVIA Holdings Inc's Other growth rate?
Other CAGR 5Y
28%
Over the last year, the Other growth was 87%. The average annual Other growth rates for IQVIA Holdings Inc have been 73% over the past three years , 28% over the past five years .
You don't have any saved screeners yet